Skip to main content Accessibility help
×
Hostname: page-component-7479d7b7d-qs9v7 Total loading time: 0 Render date: 2024-07-14T00:17:30.253Z Has data issue: false hasContentIssue false

21 - Serious hazards of transfusion (SHOT); haemovigilance

from Section 3 - Surveillance, risk and regulation

Published online by Cambridge University Press:  12 January 2010

Elizabeth M. Love
Affiliation:
Consultant Haematologist (Transfusion Medicine); Lead Clinician for Blood and Tissues Safety Assurance, NHS Blood and Transplant Manchester, Blood Centre and Central Manchester and Manchester, Children's Hospitals University, NHS Trust, Manchester, UK
John A. J. Barbara
Affiliation:
University of the West of England, Bristol
Fiona A. M. Regan
Affiliation:
HNSBT and Hammersmith Hospitals NHS Trust, London
Marcela Contreras
Affiliation:
University of the West of England, Bristol
Get access

Summary

The Serious Hazards of Transfusion scheme (SHOT), is the UK's approach to the surveillance of complications associated with the transfusion of blood and blood components. It was established as part of the UK's response to a European Commission (EC) resolution in 1995 on ‘Blood safety and self-sufficiency in the Community’ (Council Resolution, 1995). This identified that one of the main activities needed to improve public confidence in the safety of the blood supply was the development of a haemovigilance system ‘based on the existing networks for the collection of data related to the blood transfusion safety chain’. Certain aspects of haemovigilance are now a requirement in Europe, as specified in the EU Directive ‘Setting standards of quality and safety for the collection, testing, processing, storage and distribution of human blood and blood components’ (EU Directive, 2002). These requirements are now adopted in UK law (The Blood Safety and Quality Regulations, 2005).

What is haemovigilance?

Haemovigilance is a broad term which is defined in Council of Europe Guidelines as comprising the detection, gathering and analysis of untoward and unexpected effects of blood transfusion (Council of Europe, 2005). These may contribute to the safety of blood transfusion by:

  1. Providing the medical community with a reliable source of information about untoward effects of blood transfusion.

  2. Indicating corrective measures required to prevent the recurrence of some accidents or dysfunctions in the transfusion process.

  3. Warning hospitals and blood transfusion services about adverse events that could involve more individuals than a single recipient.

Its scope may cover the entire transfusion process, from collection of the donation to transfusion of the recipient and follow-up of the transfusion.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Andreu, G., Morel, P., Forestier, F.et al., (2002) Hemovigilance in France: organisation and analysis of immediate transfusion incident reports from 1994–1998. Transfusion, 42, 1356–64.CrossRefGoogle Scholar
An Organization with a Memory. Report of an Expert Group on Learning from Adverse Events in the NHS, Chaired by the Chief Medical Officer. (2000) HMSO, London, The Stationery Office.
Better Blood Transfusion (2002) Appropriate use of Blood. Circular no. HSC 2002/009. London, Department of Health.
Better Blood Transfusion (1998) Circular no. HSC 1998/1224. London, Department of Health.
Cohen, H. (2004) Highlights from the 7th SHOT Report – Taking SHOT Recommendations Forward. Presentations from SHOT meeting 2004. (available at: http//www.shot-uk.org/presentationsindex.htm).
Council of Europe (2005) Guide to the Preparation, Use and Quality Assurance of Blood Components. 11th edn. Council of Europe Publishing.
Council of Europe (1995) Council Resolution of 2 June 1995 on blood safety and self-sufficiency in the Community (95/c 164/01) OJ No. C164, 30.6.95, p1.
European Parliament (2002) EU Directive 2002/98/EC of the European Parliament L33/30 8.2.2003.
Faber, J.-C. (2004) Worldwide overview of existing haemovigilance systems. Transfusion and Apheresis Science, 31, 99–110.CrossRefGoogle ScholarPubMed
Linden, J. V., Wagner, K., VoytovichA. E., A. E.,et al. (2000) Transfusion errors in New York State: an analysis of 10 years' experience. Transfusion, 40, 1207–13.CrossRefGoogle ScholarPubMed
McClelland, B., Love, E., Lowe, S., et al. (1998) Haemovigilance: concept, Europe and UK Initiatives. Vox Sang, 74 (Suppl. 2), 431–9.CrossRefGoogle ScholarPubMed
McClelland, D. B. L., McMenamin, J. J., Moores, H. M., et al. (1996) Reducing risks in blood transfusion: process and outcome. Transfus Med, 6, 1–10.CrossRefGoogle ScholarPubMed
National Haemovigilance Office Annual Report 2003 (available at: www.ibts.ie).
Noel, L., Debeir, J. and Cosson, A. (1998) The French Hemovigilance System. Vox Sang, 74 (Suppl. 2), 441–5.CrossRefGoogle Scholar
Rebibo, D., Hauser, L., Slimani, A., et al. (2004) The French Hemovigilance System: organisation and results for 2003. Transfusion and Apheresis Science, 31, 145–53.CrossRefGoogle Scholar
Robillard, P., Nawej, K. I. and Jochem, K. (2004) The Quebec Hemovigilance System: description and results from the first two years. Transfusion and Apheresis Science, 31, 111–22.CrossRefGoogle ScholarPubMed
Serious Hazards of Transfusion, SHOT Annual Report 2003 (2004) ISBN 0 9532 789 6 4. Manchester, UK, SHOT Publishers.
Serious Hazards of Transfusion, SHOT 3rd Annual Report 1998–1999 (2000), ISBN 0 9532 789 2 1. Manchester, UK, SHOT Publishers.
Stainsby, D. (2004) Benchmarking SHOT data. Presentations from SHOT meeting 2004 (available at: http//www.shot-uk.org/presentationsindex.htm). Manchester, UK, SHOT Publishers.
The Blood Safety and Quality Regulations (2005) (available at: www.hmso.gov/uk/si2005/2005.2005.htm).
Williamson, L. M. and Love, E. M. (1998) Reporting serious hazards of transfusion: the SHOT program. Transfus Med Rev, 12, 28–35.CrossRefGoogle ScholarPubMed
Williamson, L. M., Lowe, S., Love, E. et al. (1998) Serious Hazards of Transfusion Annual Report 1996–1997. ISBN 09532 789 05 18.
Williamson, L. M. (2002) Transfusion hazard reporting: powerful data but do we know how best to use it?Transfusion, 42, 1249–52.CrossRefGoogle Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×